Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders.
David Q Beversdorf
PMID 27676697WHAT IT FOUND
There is no practice-changing finding here.
This is a narrative review of biomarker and precision-medicine approaches in autism, with no patients, interventions, or outcomes.
What this paper is
This is a narrative review about phenotyping, etiological factors, and biomarkers for precision medicine in autism spectrum disorder. It discusses genetics, imaging, environmental factors, animal models, stem cells, and proposed trial strategies. It reports no original methods, patients, interventions, or outcomes, so there is no finding to act on.
The easy way to misread this
Do not read this as evidence that biomarker-guided or precision-medicine treatments are available or effective in autism. It is a review of concepts and proposed research strategies, not tested interventions.